Advertisement

Topics

Herantis Pharma Oyj: Herantis Pharma initiates non-invasive CDNF development program, announces licensing agreement with University of Helsinki

02:05 EDT 6 Jul 2018 | FinanzNachrichten

Herantis Pharma initiates non-invasive CDNF development program, announces licensing agreement with University of Helsinki Herantis Pharma Plc Company release 6 Jul 2018 at 9:00 am Herantis Pharma...

Original Article: Herantis Pharma Oyj: Herantis Pharma initiates non-invasive CDNF development program, announces licensing agreement with University of Helsinki

NEXT ARTICLE

More From BioPortfolio on "Herantis Pharma Oyj: Herantis Pharma initiates non-invasive CDNF development program, announces licensing agreement with University of Helsinki"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...